- Sudeep Pharma IPO subscribed over 93 times on final day, led by QIBs and NIIs
- IPO includes Rs 95 crore fresh issue and 1 crore shares offer for sale by promoters
- Price band set at Rs 563-593 per share with minimum bid lot of 13 shares
Sudeep Pharma Ltd.'s initial public offer was subscribed over 93 times on the third and final day on Tuesday, led by demand from large institutions and non-institutional investors. The retail portion was also overbooked.
The IPO includes a mix of fresh issues of shares worth Rs 95 crore and an offer for sale of 1 crore shares by existing shareholders. The price band for the issue is set at Rs 563-593 per share.
Sujit Jaysukh Bhayani, Sujeet Jaysukh Bhayani HUF, Shanil Sujit Bhayani and Avani Sujit Bhayani are the promoter selling shareholders offloading stakes in the OFS segment.
ICICI Securities Ltd. and IIFL Capital Services Ltd. are the book-running lead managers for the issue and MUFG Intime India Pvt. will be the registrar of the issue.
The allotment of shares to IPO investors will be done tentatively on Nov. 26. The allotment of shares to IPO investors will be finalised tentatively on Nov. 26, and it will be credited to the demat account will be done on Nov. 27. Sudeep Pharma will list on the BSE and NSE on Nov. 28.
IPO Details
Open date: Nov. 21
Close date: Nov. 25
Price Band: Rs 563-593 per share
Allotment date: Nov. 26
Listing date: Nov. 28
OFS: 1 crore
Fresh issue: Rs 95 crore
Minimum bid: Lot size of 13 shares
Sudeep Pharma Subscription Status
Sudeep Pharma IPO has been subscribed 93.7 times as of 7:00 p.m. on Tuesday.
Qualified Institutional Buyers (QIBs): 213 times
Non-Institutional Investors (NIIS): 116.72 times
Retail Individual Investors: 15.65 times
Sudeep Pharma GMP Today
Sudeep Pharma's latest grey market premium has declined to Rs 86 apiece, from Rs 60 earlier, as per Investorgain. The GMP indicates listing price of 679 apiece, which implies 15% upside from the issue price of Rs 593.
Note: GMP does not represent official data and is based on speculation. GMP data sourced from InvestorGain.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
